Tokyo Tape
Sign in
← Sapporo Clinical Laboratory

Quarterly report · Q1

9776.TEDINET S100OYM4
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥19.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥4.6bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥132m2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥292m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥223m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥1.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥294m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥222m2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥191m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥78m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥107m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥125m2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥106m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥16.2bnat 2022-06-30Cons.Assets
Total assets¥16.1bnat 2022-03-31Cons.Assets
Total assets¥14.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥5.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥10.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥10.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥9.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥3.6bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥23.352022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥306.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.312021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥846,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥15m
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥200m
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥78m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥376m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥233m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥143m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentsegment profit2022-04-01 → 2022-06-30−¥3m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.0bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥143m
—segment totalsegment profit2022-04-01 → 2022-06-30¥275m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥144m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥290m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥351,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥11m
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥304m
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥131m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥710m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥170m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥539m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥7m
—segment totalrevenue2021-04-01 → 2021-06-30¥5.2bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥4.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥539m
—segment totalsegment profit2021-04-01 → 2021-06-30¥442m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥5.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥540m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥453m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Intangible assetsPrior1YearInstant60128000JPY
Intangible assetsCurrentQuarterInstant59447000JPY
Investment securitiesPrior1YearInstant142407000JPY
Investment securitiesCurrentQuarterInstant137704000JPY
Long term loans receivablePrior1YearInstant7000JPY
Long term loans receivableCurrentQuarterInstant－JPY
Long term prepaid expensesPrior1YearInstant29916000JPY
Long term prepaid expensesCurrentQuarterInstant27099000JPY
Guarantee deposits ioaPrior1YearInstant179172000JPY
Guarantee deposits ioaCurrentQuarterInstant177185000JPY
Deferred tax assetsPrior1YearInstant162164000JPY
Deferred tax assetsCurrentQuarterInstant162048000JPY
Other ioaPrior1YearInstant235146000JPY
Other ioaCurrentQuarterInstant237752000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-16841000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-16841000JPY
Investments and other assetsPrior1YearInstant731974000JPY
Investments and other assetsCurrentQuarterInstant724949000JPY
Noncurrent assetsPrior1YearInstant8919805000JPY
Noncurrent assetsCurrentQuarterInstant8899001000JPY
AssetsPrior1YearInstant16149449000JPY
AssetsCurrentQuarterInstant16173114000JPY
Notes and accounts payable tradePrior1YearInstant2258565000JPY
Notes and accounts payable tradeCurrentQuarterInstant2378408000JPY
Current portion of long term loans payablePrior1YearInstant133692000JPY
Current portion of long term loans payableCurrentQuarterInstant133692000JPY
Lease obligations clPrior1YearInstant106041000JPY
Lease obligations clCurrentQuarterInstant114495000JPY
Income taxes payablePrior1YearInstant294056000JPY
Income taxes payableCurrentQuarterInstant109021000JPY
Provision for bonusesPrior1YearInstant120975000JPY
Provision for bonusesCurrentQuarterInstant68067000JPY
Accounts payable otherPrior1YearInstant125075000JPY
Accounts payable otherCurrentQuarterInstant247060000JPY
Asset retirement obligations clPrior1YearInstant28000000JPY
Asset retirement obligations clCurrentQuarterInstant28000000JPY
Other clPrior1YearInstant215389000JPY
Other clCurrentQuarterInstant271395000JPY
Current liabilitiesPrior1YearInstant3281795000JPY
Current liabilitiesCurrentQuarterInstant3350140000JPY
Long term loans payablePrior1YearInstant1732321000JPY
Long term loans payableCurrentQuarterInstant1698898000JPY
Lease obligations nclPrior1YearInstant610978000JPY
Lease obligations nclCurrentQuarterInstant592962000JPY
Provision for directors retirement benefitsPrior1YearInstant66870000JPY
Provision for directors retirement benefitsCurrentQuarterInstant62247000JPY
Net defined benefit liabilityPrior1YearInstant16107000JPY
Net defined benefit liabilityCurrentQuarterInstant16473000JPY
Long term accounts payable otherPrior1YearInstant97363000JPY
Long term accounts payable otherCurrentQuarterInstant94311000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass